Stanozolol
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB06718 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | C1 inhibitor deficiency | KG + DL |
| 2 | serpinopathy with toxic serpin polymerization | KG + DL |
| 3 | fetal erythroblastosis | KG + DL |
| 4 | Peyronie disease | KG + DL |
| 5 | renal tubular acidosis | KG + DL |
| 6 | immune-mediated necrotizing myopathy | KG + DL |
| 7 | antisynthetase syndrome | KG + DL |
| 8 | complement component C1s deficiency | KG + DL |
| 9 | focal myositis | KG + DL |
| 10 | idiopathic eosinophilic myositis | KG + DL |
| 11 | inflammatory myopathy with abundant macrophages | KG + DL |
| 12 | posterior leukoencephalopathy syndrome | KG + DL |
| 13 | Camurati-Engelmann disease | KG + DL |
| 14 | acquired angioedema | KG + DL |
| 15 | geleophysic dysplasia | KG + DL |
| 16 | IgA nephropathy, susceptibility to | KG + DL |
| 17 | aortic valve insufficiency | KG + DL |
| 18 | retinal telangiectasia | KG + DL |
| 19 | carcinosarcoma | KG + DL |
| 20 | IgA glomerulonephritis | KG + DL |
| 21 | osteopetrosis | KG + DL |
| 22 | penile fibromatosis | KG + DL |
| 23 | nephrosclerosis | KG + DL |
| 24 | dermatomyositis | KG + DL |
| 25 | arteriosclerotic retinopathy | KG + DL |
| 26 | retinal microaneurysm | KG + DL |
| 27 | pseudo-von Willebrand disease | KG + DL |
| 28 | alkaptonuria | KG + DL |
| 29 | autoimmune hemolytic anemia | KG + DL |
| 30 | papillomatosis | KG + DL |
| 31 | vertebral artery occlusion | KG + DL |
| 32 | acquired aplastic anemia | KG + DL |
| 33 | papilloma | KG + DL |
| 34 | potassium-aggravated myotonia | KG + DL |
| 35 | retinal artery occlusion | KG + DL |
| 36 | primary release disorder of platelets | KG + DL |
| 37 | squamous papilloma | KG + DL |
| 38 | familial acanthosis nigricans | KG + DL |
| 39 | deafness, congenital, with total albinism | KG + DL |
| 40 | palmar fibromatosis | KG + DL |
| 41 | fingerprint body myopathy | KG + DL |
| 42 | infantile digital fibromatosis | KG + DL |
| 43 | hyperphosphatemia (disease) | KG + DL |
| 44 | urticaria, familial localized heat | KG + DL |
| 45 | Tietz syndrome | KG + DL |
| 46 | Buschke-Ollendorff syndrome | KG + DL |
| 47 | Ledderhose disease | KG + DL |
| 48 | benign Samaritan congenital myopathy | KG + DL |
| 49 | Dahlberg-Borer-Newcomer syndrome | KG + DL |
| 50 | Ehlers-Danlos syndrome, periodontal | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.